Cargando…
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine
INTRODUCTION: COVID-19 vaccination seems to be the most pertinent pharmacologic public health measure to control the pandemic. Reactogenicity symptoms were frequent in vaccine recipients mostly mild to moderate and commonly reported after the second dose. However, there is a lack of data in patients...
Autores principales: | Tissot, Noémie, Brunel, Anne-Sophie, Bozon, Fabienne, Rosolen, Béatrice, Chirouze, Catherine, Bouiller, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295016/ https://www.ncbi.nlm.nih.gov/pubmed/34332800 http://dx.doi.org/10.1016/j.vaccine.2021.07.047 |
Ejemplares similares
-
Caractéristiques de la COVID-19 chez les patients âgés de 75 ans et plus, hospitalisés
por: Gilis, M., et al.
Publicado: (2020) -
Facteurs de risque de COVID-19 chez les soignants
por: Lebreton, C., et al.
Publicado: (2020) -
Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
por: Razanamahery, J., et al.
Publicado: (2020) -
Does type of immunosupression influence the course of Covid-19 infection?
por: Razanamahery, J., et al.
Publicado: (2020) -
COVID-19 as a cause of immune thrombocytopenia
por: Humbert, S., et al.
Publicado: (2020)